AUG 01, 2017 05:49 AM PDT

Kidney Recipients Have Higher Risks of Melanoma

WRITTEN BY: Xuan Pham

Melanoma, the most dangerous form of skin cancer, seems to be an opportunistic striker. Earlier this year, scientists confirmed that patients with Parkinson’s disease were more likely to develop melanoma. Now it seems kidney transplant recipients are also at higher risk of developing the deadly skin cancer.

Left: melanomas. Right: normal moles. \\ Image credit: Wikipedia.org

In a study of over 105,000 kidney transplant recipients from between 2004 to 2012, researchers found that 488 patients went on to receive a melanoma diagnosis after the transplant.

Further analysis of the kidney transplant and melanoma link revealed a pattern that was not previously seen. Most of the kidney recipients were white, male, and older (about 11 years on average) than the healthy counterparts.

It’s been hypothesized that organ recipients have an increased chance of getting cancers because of the constant immunosuppressants that they must take in order to prevent organ failure. Indeed, lifelong exposure to these drugs has been most commonly linked to increased risks for non-Hodgkin lymphoma, and cancers of the lung, kidney, and liver.

When the researchers teased apart the type of immunosuppressant drugs patients were taking, they found that the drugs cyclosporine and sirolimus were more common in those who developed melanoma.

"Renal transplant recipients had greater risk of developing melanoma than the general population. We believe that the risk factors we identified can guide clinicians in providing adequate care for patients in this vulnerable group," the authors concluded.

Although the study establishes a link between the two diseases, it does not provide a biological mechanism behind the association. However, the results suggest that kidney transplant recipients should be closely monitored for this disease, as well as other cancers. On another level, the link offers scientists clues into how melanoma strikes. And understanding the interplay between the immune system and how the disease develops could inform better treatment targets for patients in the future.

Additional sources: The JAMA Network Journals via Science Daily

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 27, 2018
Cancer
JUN 27, 2018
Engineered Poliovirus in Clinical Trials for Glioblastoma
Glioblastoma is a very difficult cancer to treat; researchers look to an engineered poliovirus for novel targeted approach for grade IV patients....
JUL 17, 2018
Cancer
JUL 17, 2018
Large Multifactorial NIH Study Announced for Prostate Cancer Aggressiveness in African-American Men
The largest coordinated study on Prostate cancer aims to look at both genetic and environmental factors that lead to increased risk and cancer aggressiveness in African-American men compared...
AUG 29, 2018
Immunology
AUG 29, 2018
Artificial Intelligence Predicts Response to Immunotherapy
Artificial intelligence can process CT scan images to determine biological and clinical information that can predict immunotherapy efficacy thanks to machine learning....
SEP 14, 2018
Health & Medicine
SEP 14, 2018
Can You Get Addicted to Tanning at the Gym?
Do you know what GTL means? If you're a fan of the reality series "The Jersey Shore" then you know it stands for "Gym, Tan, Laundry"...
OCT 06, 2018
Drug Discovery
OCT 06, 2018
New Class of Drugs for Breast Cancer Therapy
Scientists at Stevens Institute of Technology have designed a new class of molecules that may hold the potential to add to the arsenal of drugs actively be...
OCT 07, 2018
Videos
OCT 07, 2018
Certain Foods Encourage a Gut Microbe, and Colon Cancer
Researchers reveal more evidence that refined grains and sugars and processed meats are bad for colon health....
Loading Comments...